Skip to main content
SpringerLink
Log in

Onkologie und Tumoren

  • Chapter
Facharztwissen Urologie

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Arbeitsgemeinschaft der wissenschaftlichen Medizinischen Fachgesellschaften/AWMF (2000) Interdisziplinäre kurzgefaßte Leitlinien der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Urologie. Nierenzellkarzinom. AWMF-Leitlinien-Register Nr. 032/037, 2000, A25 331 ff.

    Google Scholar 

  • Bonsib SM, Gibson D, Mhoon M, Greene GF (2000) Renal sinus involvement in renal cell carcinomas. Am J Surg Pathol 24:451–458

    CAS  PubMed  Google Scholar 

  • Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF, Pairolero PC (1994) Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 57:339–344

    CAS  PubMed  Google Scholar 

  • Elson PJ, Witte RS, Trump DL (1988) Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48:7310–7213

    CAS  PubMed  Google Scholar 

  • Flanigan RC, Salmon SE, Blumenstein BA et al. (2001) Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345:1655–1659

    CAS  PubMed  Google Scholar 

  • Fossa SD, Lien HH, Lindegaard M (1991) Effect of recombinant interferon alfa on bone metastases of renal-cell carcinoma. N Engl J Med 324:633–634

    CAS  PubMed  Google Scholar 

  • Gleave ME, Elhilali M, Fradet Y et al. (1998) Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group. N Engl J Med 338:1265–1271

    CAS  PubMed  Google Scholar 

  • Hafez KS, Fergany AF, Novick AC (1999) Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 162:1930–1933

    CAS  PubMed  Google Scholar 

  • Heinzer H, Huland E, Aalamian M, Huland H (1999) Treatment of pulmonary metastases from kidney cell carcinoma with inhalational interleukin-2. 10-year experience Hamburger Unicenter. Urologe (A) 38:466–473

    CAS  PubMed  Google Scholar 

  • Heinzer H, Mir TS, Huland E, Huland H (1999) Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy. J Clin Oncol 17:3612–3620

    CAS  PubMed  Google Scholar 

  • Maher ER, Yates JR, Harries R, Benjamin C et al. (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151-11–63

    Google Scholar 

  • Maher ER, Webster AR, Moore AT (1995) Clinical features and molecular genetics of Von Hippel-Lindau disease. Ophthalmic Genet 16:79–84

    CAS  PubMed  Google Scholar 

  • Matson MA, Cohen EP (1990) Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore) 69:217–226

    CAS  PubMed  Google Scholar 

  • Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R (2001) Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358:966–970

    CAS  PubMed  Google Scholar 

  • Negrier S, Escudier B, Lasset C et al. (1998) Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d’Immunotherapie. N Engl J Med 338:1272–1278

    CAS  PubMed  Google Scholar 

  • Pomer S, Klopp M, Steiner HH, Brkovic D, Staehler G, Cabillin-Engenhart R (1997) Brain metastases in renal cell carcinoma. Results of treatment and prognosis. Urologe (A) 36:117–125

    CAS  PubMed  Google Scholar 

  • Riese W, Goldenberg K, Freytag A (1998) Spontanremissionen und deren Einflu mit metastasiertem Nierenzellkarzinom. In: Heim M, Schwarz R (Hrsg) Spontanremissionen in der Onkologie. Schattauer, Stuttgart, S 223–240

    Google Scholar 

  • Schlichter A, Wunderlich H, Junker K, Kosmehl H, Zermann DH, Schubert J (2000) Where are the limits of elective nephron-sparing surgery in renal cell carcinoma? Eur Urol 37:517–520

    CAS  PubMed  Google Scholar 

  • Storkel S (1999) Epithelial tumors of the kidney. Pathological subtyping and cytogenetic correlation. Urologe A 38:425–432

    CAS  PubMed  Google Scholar 

  • Wittekind CH, Bootz F, Meyer HJ (2002) TNM. Klassifikation maligner Tumoren. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Yagoda A, Petrylak D, Thompson S (1993) Cytotoxic chemotherapy for advanced renal cell carcinoma. Urol Clin North Am 20:303–321 (Review)

    CAS  PubMed  Google Scholar 

Literatur

  • Arnaldi G, Angeli A, Atkinson AB et al. (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602

    CAS  PubMed  Google Scholar 

  • Barzon L, Sonino N, Fallo F, Palu G, Boscaro M (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273–285

    CAS  PubMed  Google Scholar 

  • Brauckhoff M, Gimm O, Dralle H (2004) Preoperative and surgical therapy in sporadic and familial pheochromocytoma. Front Horm Res 31:121–144

    PubMed  Google Scholar 

  • Ferrari P, Bonny O (2003) Forms of mineralocorticoid hypertension. Vitam Horm 66:113–156

    CAS  PubMed  Google Scholar 

  • Ilias I, Pacak K (2004) Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89:479–491

    CAS  PubMed  Google Scholar 

  • Jockenhövel F, Fottner C (2001) Der Nebennierentumor — Diagnostik und Therapie. Urologe (A) 40:148–159

    PubMed  Google Scholar 

  • Jockenhövel F, Kuck W, Hauffa B et al. (1992) Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas). J Endocrin Invest 15:331–337

    Google Scholar 

  • Jockenhövel F, Hörmann R, Mann K (1995) Tumors of the adrenals. Onkologie 18:317–323

    Google Scholar 

  • Lal G, Duh QY (2003) Laparoscopic adrenalectomy — indications and technique. Surg Oncol 12:105–123

    PubMed  Google Scholar 

  • Morris DG, Grossmann AB (2003) Dynamic tests in the diagnosis and differential diagnosis of Cushing’s syndrome. J Endocrinol Invest 26(Suppl):64–73

    CAS  PubMed  Google Scholar 

  • Walz MK, Peitgen K, Walz MV et al. (2001) Posterior retroperitoneoscopic adrenalectomy: lessons learned within five years. World J Surg 25:728–734

    CAS  PubMed  Google Scholar 

  • Wheeler MH, Harris DA (2003) Diagnosis and management of primary aldosteronism. World J Surg 27:627–631

    PubMed  Google Scholar 

Literatur

  • Adam U, Mack D, Forstner R, Fritzenwallner A, Frick J (1999) Conservative treatment of acute Ormond’s disease. Techn Urol 5:54–56

    CAS  Google Scholar 

  • al-Musawi D, Mitchenere P, al-Akraa M (1998) Idiopathic retroperitoneal fibrosis treated with tamoxifen only. Br J Urol 82:442–443

    CAS  PubMed  Google Scholar 

  • Bachmann G, Bauer T, Rau WS (1995) MRI and CT in diagnosis and follow-up of idiopathic retroperitonealfibrosis. Radiologe 35:200–207

    CAS  PubMed  Google Scholar 

  • Baker LR, Mallinson WJ, Gregory MC et al, (1987) Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 60:497–503

    CAS  PubMed  Google Scholar 

  • Dalla-Palma L, Rocca-Rossetti S, Pozzi-Mucelli RS, Rizzatto G (1981) Computed tomography in the diagnosis of retroperitoneal fibrosis. Urol Radiol 3:77–83

    CAS  PubMed  Google Scholar 

  • Heidenreich A, Derakhshani P, Neubauer S, Krug B (2000) Treatment outcomes in primary and secondary retroperitoneal fibrosis. Urologe (A) 39:141–118

    CAS  PubMed  Google Scholar 

  • Lindell OI, Lehtonen TA (1988) Surgical treatment of ureteric obstruction in idiopathic retroperitoneal fibrosis. Scand J Urol Nephrol Suppl 110:299–302

    CAS  Google Scholar 

  • Osborn DE, Rao PN, Barnard RJ, Ackrill P, Ralston AJ, Best JJ (1981) Surgical management of idiopathic retroperitoneal fibrosis. Br J Urol 53:292–296

    CAS  PubMed  Google Scholar 

Literatur

  • Al-Sukhun S and Hussain M (2003) Current understanding of the biology of advanced bladder cancer. Cancer 97:2064–75

    CAS  PubMed  Google Scholar 

  • Althausen AF, Prout GR, Jr and Daly JJ (1976) Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116:575–80

    CAS  PubMed  Google Scholar 

  • Aveyard P, Adab P, Cheng KK, Wallace DM, Hey K and Murphy MF (2002) Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int 90:228–39

    CAS  PubMed  Google Scholar 

  • Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG and Nichols PW (1995) Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87:1603–12

    CAS  PubMed  Google Scholar 

  • Bochner BH, Esrig D, Groshen S, Dickinson M, Weidner N, Nichols PW, Skinner DG and Cote RJ (1997) Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer. Clin Cancer Res 3:1615–22

    CAS  PubMed  Google Scholar 

  • Bohle A and Bock PR (2004) Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 63: 682–6; discussion 686-7

    CAS  PubMed  Google Scholar 

  • Botteman MF, Pashos CL, Hauser RS, Laskin BL and Redaelli A (2003) Quality of life aspects of bladder cancer: a review of the literature. Qual Life Res 12:675–88

    CAS  PubMed  Google Scholar 

  • Cairns P, Shaw ME and Knowles MA (1993) Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene 8:1083–5

    CAS  PubMed  Google Scholar 

  • Crew JP, O’Brien T, Bicknell R, Fuggle S, Cranston D and Harris AL (1999) Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol 161:799–804

    CAS  PubMed  Google Scholar 

  • de Wit R and Bellmunt J (2003) Overview of gemcitabine triplets in metastatic bladder cancer. Crit Rev Oncol Hematol 45:191–7

    PubMed  Google Scholar 

  • D’Hallewin MA, Bezdetnaya L and Guillemin F (2002) Fluorescence detection of bladder cancer: a review. Eur Urol 42:417–25

    CAS  PubMed  Google Scholar 

  • D’Hallewin MA, Kamuhabwa AR, Roskams T, De Witte PA and Baert L (2002) Hypericin-based fluorescence diagnosis of bladder carcinoma. BJU Int 89:760–3

    PubMed  Google Scholar 

  • Elmajian DA (2001) Indications for urethrectomy. Semin Urol Oncol 19:37–44

    CAS  PubMed  Google Scholar 

  • Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA and Cote RJ (1994) Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331:1259–64

    CAS  PubMed  Google Scholar 

  • Filbeck T, Roessler W, Knuechel R, Straub M, Kiel HJ and Wieland WF (1999) 5-aminolevulinic acid-induced fluorescence endoscopy applied at secoodary transurethral resection after conventional resection ofprimary superficial bladder tumors. Urology 53:77–81

    CAS  PubMed  Google Scholar 

  • Gee J, Sabichi AL and Grossman HB (2002) Chemoprevention of superficial bladder cancer. Crit Rev Oncol Hematol 43: 277–86

    PubMed  Google Scholar 

  • Glas AS, Roos D, Deutekom M, Zwinderman AH, Bossuyt PM and Kurth KH (2003) Tumor markers in the diagnosis of primary bladder cancer. A systematic review. J Urol 169:1975–82

    PubMed  Google Scholar 

  • Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP, Jr, Raghavan D et al. (2003) Neoadjuvant chemotherapy plus cystectomy oompared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859–66

    CAS  PubMed  Google Scholar 

  • Gschwend JE, Fair WR and Vieweg J (2000) Raifical cystectomy for invasive bladder cancer: contemporary results and remaining controversies. Eur Urol 38:121–30

    CAS  PubMed  Google Scholar 

  • Hautmann RE (2000) Which patients with transitional cell carcinoma of the bladder or prostatic urethra are candidates for an orthotopic neobladder? Curr Urol Rep 1:173–9

    CAS  PubMed  Google Scholar 

  • Herr HW (2003) Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 61:105–8

    PubMed  Google Scholar 

  • Irie A (2003) Advances in gene therapy for bladder cancer. Curr Gene Ther 3:1–11

    CAS  PubMed  Google Scholar 

  • Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM and Carroll PR (1995) Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 154:69–71

    CAS  PubMed  Google Scholar 

  • Jichlinski P and Leisinger HJ (2001) Photodynamic therapy in superficial bladder cancer: past, present and future. Urol Res 29:396–405

    CAS  PubMed  Google Scholar 

  • Kiemeney LA, Witjes JA, Heijbroek RP, Debruyne FM and Verbeek AL (1994) Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. Eur J Cancer 30A:1621–5

    CAS  PubMed  Google Scholar 

  • Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F and Hofstetter A (1996) Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155:105–9; discussion 109-10

    CAS  PubMed  Google Scholar 

  • Kuczyk M, Turkeri L, Hammerer P and Ravery V (2003) Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer? Eur Urol 44:57–64

    CAS  PubMed  Google Scholar 

  • Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM et al. (2000) Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163:1124–9

    CAS  PubMed  Google Scholar 

  • Lawler LP (2003) MR imaging of the bladder. Radiol Clin North Am 41:161–77

    PubMed  Google Scholar 

  • Leissner J, Hohenfellner R, Thuroff JW and Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85:817–23

    CAS  PubMed  Google Scholar 

  • Lopez-Beltran A and Montironi R (2004) Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 46:170–6

    PubMed  Google Scholar 

  • Lotan Y and Roehrborn CG (2003) Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61:109–18; discussion 118

    PubMed  Google Scholar 

  • Matin SF (2003) Laparoscopic approaches to urologic malignancies. Curr Treat Options Oncol 4:373–83

    PubMed  Google Scholar 

  • Mills RD and Studer UE (1999) Metabolic consequences of continent urinary diversion. J Urol 161:1057–66

    CAS  PubMed  Google Scholar 

  • Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN and Studer UE (2001) Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166:19–23

    CAS  PubMed  Google Scholar 

  • Miyake H, Eto H, Arakawa S, Kamidono S and Hara I (2002) Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer. J Urol 167:1282–7

    PubMed  Google Scholar 

  • Moonen L (2003) Indications and outcome of radiotherapy for invasive bladder cancer: review of developments during 2002. Curr Opin Urol 13:385–7

    PubMed  Google Scholar 

  • Negri E and La Vecchia C (2001) Epidemiology and prevention of bladder cancer. Eur J Cancer Prev 10:7–14

    CAS  PubMed  Google Scholar 

  • Nilsson S, Ragnhammar P, Glimelius B and Nygren P (2001) A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol 40:371–90

    CAS  PubMed  Google Scholar 

  • Nurmi M, Katevuo K and Puntala P (1988) Reliability of CT in preoperative evaluation of bladder carcinoma. Scand J Urol Nephrol 22:125–8

    CAS  PubMed  Google Scholar 

  • Palou J, Laguna P, Millan-Rodriguez F, Hall RR, Salvador-Bayarri J and Vicente-Rodriguez J (2001) Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors. J Urol 165:1488–91

    CAS  PubMed  Google Scholar 

  • Patard JJ, Rodriguez A and Lobel B (2003) The current status of intravesical therapy für superficial bladder cancer. Curr Opin Urol 13:357–62

    PubMed  Google Scholar 

  • Patton SE, Hall MC and Ozen H (2002) Bladder cancer. Curr Opin Oncol 14:265–72

    PubMed  Google Scholar 

  • Quek ML, Quinn DI, Daneshmand S and Stein JP (2003) Molecular prognostication in bladder cancer — a current perspective. Eur J Cancer 39:1501–10

    CAS  PubMed  Google Scholar 

  • Raghavan D (2003) Progress in the chemotherapy of metastatic cancer of the urinary tract. Cancer 97:2050–5

    CAS  PubMed  Google Scholar 

  • Riedl CR, Daniltchenko D, Koenig F, Simak R, Loening SA and Pflueger H (2001) Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 165:1121–3

    CAS  PubMed  Google Scholar 

  • Shelley MD, Barber J, Wilt TJ and Mason MD (2003) Surgery versus radiotherapy for muscle invasive bladder cancer? Clin Oncol (R Coll Radiol) 15:167–8

    CAS  Google Scholar 

  • Simon MA, Lokeshwar VB and Soloway MS (2003) Current bladder cancer tests: unnecessary or beneficial? Crit Rev Oncol Hematol 47:91–107

    PubMed  Google Scholar 

  • Smith JA, Jr and Whitmore WF, Jr (1981) Regional lymph node metastasis from bladder cancer. J Urol 126:591–3

    PubMed  Google Scholar 

  • Smith ND, Rubenstein JN, Eggener SE and Kozlowski JM (2003) The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol 169:1219–28

    CAS  PubMed  Google Scholar 

  • Sozen S, Eskicorabci S and Ozen H (2003) Urinary markers for urothelial cancer. BJU Int 92:531–3

    CAS  PubMed  Google Scholar 

  • Stenzl A, Bartsch G and Rogatsch H (2002) The remnant urothelium after reconstructive bladder surgery. Eur Urol 41:124–31

    PubMed  Google Scholar 

  • Sternberg CN (2002) Current perspectives in muscle invasive bladder cancer. Eur J Cancer 38:460–7

    CAS  PubMed  Google Scholar 

  • Sylvester RJ, Oosterlinck W and van der Meijden AP (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171:2186–90, quiz 2435

    PubMed  Google Scholar 

  • Vallancien G, Abou El Fettouh H, Cathelineau X, Baumert H, Fromont G and Guillonneau B (2002) Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol 168:2413–7

    PubMed  Google Scholar 

  • von der Maase H (2002) Current and future perspectives in advanced bladder cancer: is there a new standard? Semin Oncol 29:3–14

    PubMed  Google Scholar 

  • Yossepowitch O, Dalbagni G, Golijanin D, Donat SM, Bochner BH, Herr HW, Fair WR and Russo P (2003) Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. J Urol 169:177–81

    PubMed  Google Scholar 

Literatur

  • Dodd LG, Johnston WW, Robertson CN and Layfield LJ (1997) Endoscopic brush cytology of the upper urinary tract. Evaluation of its efficacy and potential limitations in diagnosis. Acta Cytol 41:377–84

    CAS  PubMed  Google Scholar 

  • Vicente-Rodriguez J (2001) Upper tract transitional cell carcinoma following cystectomy for bladder cancer. Eur Urol 40:318–23

    PubMed  Google Scholar 

  • Kenworthy P, Tanguay S and Dinney CP (1996) The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J Urol 155:501–3

    CAS  PubMed  Google Scholar 

  • Kirkali Z and Tuzel E (2003) Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47:155–69

    PubMed  Google Scholar 

  • Lerner SE, Blute ML, Richardson RL and Zincke H (1996) Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract. Mayo Clin Proc 71:945–50

    CAS  PubMed  Google Scholar 

  • Liu JB, Bagley DH, Conlin MJ, Merton DA, Alexander AA and Goldberg BB (1997) Endoluminal sonographic evaluation of ureteral and renal pelvic neoplasms. J Ultrasound Med 16:515–21; quiz 523–4

    CAS  PubMed  Google Scholar 

  • Martinez-Pineiro JA, Garcia Matres MJ and Martinez-Pineiro L (1996) Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol 156:377–85

    CAS  PubMed  Google Scholar 

  • Munoz JJ and Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164:1523–5

    CAS  PubMed  Google Scholar 

  • Rabbani F, Perrotti M, Russo P and Herr HW (2001) Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance. J Clin Oncol 19:94–100

    CAS  PubMed  Google Scholar 

  • Sadek S, Soloway MS, Hook S and Civantos F (1999) The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer. J Urol 161:77–9

    CAS  PubMed  Google Scholar 

Literatur

  • Awakura Y, Nonomura M, Itoh N et al. (2003) Adenocarcinoma of the female urethral diverticulum treated by multimodality therapy. Int J Urol 10:281–283

    PubMed  Google Scholar 

  • Basler JW (2002) Chemotherapy for urethral cancer. In: Hamdy FC, Neal DE, Catalona WJ (Editors): Management of Urologie Malignancies, Churchill Livingstone London 546–548

    Google Scholar 

  • Dinney CP, Johnson DE, Swanson DA, Babaian RJ, von Eschenbach AC (1994) Therapy and prognosis for male anterior urethral carcinoma: an update. Urology 43:506–514

    CAS  PubMed  Google Scholar 

  • Donat SM, Cozzi PJ, Herr HW (2002) Surgery of penile and urethral carcinoma. In: Walsh PC (Editor in Chief): Campbell’s Urology, 8th Edition, Saunders, S2983–2999

    Google Scholar 

  • Eng TY, Naguib M, Galang T, Fuller CD (2003) Retrospective study if the treatment of urethral cancer. Am J Clin Oncol 26:558–562

    PubMed  Google Scholar 

  • Gheiler EL, Teffili MV, Tiguert R et al. (1998) Management of primary urethral cancer. Urology 52:487–493

    CAS  PubMed  Google Scholar 

  • Gnanapragasam VJ, Leung HY (2002) Surgery of carcinoma of the urethra. In: Hamdy FC, Neal DE, Catalona WJ (Editors): Management of Urologie Malignancies, Churchill Livingstone London 538–541

    Google Scholar 

  • Grigsby P (2002) Radiotherapy for urethral cancer. In: Hamdy FC, Neal DE, Catalona WJ (Editors): Management of Urologie Malignancies, Churchill Livingstone London, 541–545

    Google Scholar 

  • Hakenberg OW, Franke HJ, Froehner M, Wirth MP (2001) The treatment of primary urethral carcinoma — the dilemmas of a rare condition: experience with partial urethrectomy and adjuvant chemotherapy. Onkologie 24:48–52

    CAS  PubMed  Google Scholar 

  • Melickow MM, Roberts TW (1978) Pathology and natural history of urethral tumors in males. Review of 142 cases. Urology 11:83–89

    Google Scholar 

  • Morikawa K, Togashi K, Minami S et al. (1995) MR and CR appearance of urethral clear cell adenocarcinoma in women. J Computer Assisted Tomography 19:1001–1003

    CAS  Google Scholar 

Literatur

  • Colberg JW, Andriole GL, Catalona WJ (1997) Long-term follow-up of men undergoing modified inguinal lymphadenectomy for carcinoma of the penis. BJU 79:54–57

    CAS  PubMed  Google Scholar 

  • Culkin DJ, Beer TM (2003) Advanced penile carcinoma. J Urol 170:359–365

    PubMed  Google Scholar 

  • Derakshani P, Neubauer S, Braun M, Bargmann H, Heidenreich A, Engelmann U (1999) Results and 10-year follow-up in patients with squamous cell carcinoma of the penis. Urol Int 62:238–244

    Google Scholar 

  • Doehn C, Feyerabend T (2001) Radiochemotherapy of penis carcinoma. Urology 40:313–314

    CAS  Google Scholar 

  • Frimberger D, Hungerhuber E, Zaak D, Waidelich R, Hofstetter A, Schneede P (2002) Penile carcinoma. Is Nd: YAG laser therapy radical enough. J Urol 168:2418–2421

    CAS  PubMed  Google Scholar 

  • Haas GP, Blumenstein BA, Gagliano RG, Russell CA, Rivkin SE, Culkin DJ, Wolf M, Crawford ED (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group Study. J Urol 161:1823–1825

    CAS  PubMed  Google Scholar 

  • Horenblas S (2001) Lymphadenectomy for squamous cell carcinoma of the penile. Part 2: the role and technique of lymph node dissection. BJU Int 88:473–483

    CAS  PubMed  Google Scholar 

  • Horenblas S, Van Tinteren H, Delamarre JFM, Lustig V, van Waardenburg FW (1993) Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 149:492–497

    CAS  PubMed  Google Scholar 

  • Horenblas S, Van Tinteren H, Delamarre JFM, Moonen LM, Lustig V, van Waardenburg EW (1993) Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 149:492–497

    CAS  PubMed  Google Scholar 

  • Horenblas S, Van Tinteren H, Delemarre JFM, Boon TA, Moonen LMF, Lustig V (1992) Squamous cell carcinoma of the penis. II. Treatment of the primary tumor. J Urol 147:1533–1538

    CAS  PubMed  Google Scholar 

  • Jacobellis U (2003) Modified radical inguinal lymphadenectomy for carcinoma of the penis: technique and results. J Urol 169:1349–1352

    PubMed  Google Scholar 

  • Mobilio G, Ficarra V (2001) Genital treatment of penile carcinoma. Curr Opin Urol 11:299–304

    CAS  PubMed  Google Scholar 

  • Pizzocaro G, Piva L, Bandieramonte G, Tana S (1997) Up-to-date management of carcinoma of the penis. Eur Urol 32:5–15

    CAS  PubMed  Google Scholar 

  • Sarin R, Norman AR, Steel GG, Horwich A (1997) Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. Int J Radiat Oncol Biol Phys 38:713–722

    CAS  PubMed  Google Scholar 

  • Slaton JW, Morgenstern N, Levy DA, Santos MW Jr, Tamboli R, Ro JY, Ayala AG, Pettaway CA (2001) Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol 165:1138–1142

    CAS  PubMed  Google Scholar 

  • Sobin LH, Wittekind Ch (2002) TNM Classification of Malignant Tumors. 6th edn. New York: Wiley-Liss, www.wiley.com/go/tnm

    Google Scholar 

  • Stancik I, Holtl W (2003) Penile cancer: review of the recent literature. Curr Opin Urol 13:467–472

    PubMed  Google Scholar 

  • Tanis PJ, Lont AP, Meinhardt W, Olmos RA, Nieweg OE, Horenblas S (2002) Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol 168:76–80

    CAS  PubMed  Google Scholar 

Literatur

  • Adolfsson J (1995). Radical prostatectomy, radiotherapy or deferred treatment for localized prostate cancer? Cancer Surv 23:141–148

    CAS  PubMed  Google Scholar 

  • Albertsen PC, Hanley JA et al. (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280:975–980

    CAS  PubMed  Google Scholar 

  • Baretton GB, Pacelli A et al. (1994) Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study. Hum Pathol 25:506–513

    CAS  PubMed  Google Scholar 

  • Berruti A, Dogliotti L et al. (2001) Metabolic bone disease induced by prostate cancer: rationale for the use of bisphosphonates. J Urol 166:2023–2031

    CAS  PubMed  Google Scholar 

  • Bishoff JT, Motley G et al. (1998) Incidence of fecal and urinary incontinence following radical perineal and retro-pubic prostatectomy in a national population. J Urol 160:454–458

    CAS  PubMed  Google Scholar 

  • Bolla M (2003) Treatment of localized or locally advanced prostate cancer: the clinical use of radiotherapy« EAU Update series 1:23–31

    Google Scholar 

  • Bolla M, Gonzalez D et al. (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295–300

    CAS  PubMed  Google Scholar 

  • Chan TY, Partin AW et al. (2000) Prognostic significance of Gleason Score 3 + 4 versus Gleason Score 4 + 3 tumour at radical prostatectomy. Urology 56:823–827

    CAS  PubMed  Google Scholar 

  • Catalona WJ (1994) Expectant management and the natural history of localized prostate cancer. J Urol 152:1751–1752

    CAS  PubMed  Google Scholar 

  • Cheville JC, Dundore PA et al. (1995) Leiomyosarcoma of the prostate. Report of 23 cases. Cancer 76:1422–1427

    CAS  PubMed  Google Scholar 

  • Clark LC, Combs GF Jr et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957

    CAS  PubMed  Google Scholar 

  • Cox JD (1997) The American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement guidelines for PSA failure following radiation therapy. Int J Radiat Oncol Biol Phys 37:1035–1041

    Google Scholar 

  • D’Amico AV, Whittington R et al. (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974

    CAS  PubMed  Google Scholar 

  • Dundore PA, Cheville JC et al. (1995) Carcinosarcoma of the prostate. Report of 21 cases. Cancer 76:1035–1042

    CAS  PubMed  Google Scholar 

  • Epstein JI, Partin AW et al. (2000) Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology 56:283–288

    CAS  PubMed  Google Scholar 

  • Froehner M, Koch R et al. (2003) Preoperative cardiopulmonary risk assessment as predictor of early non-cancer and overall mortality after radical prostatectomy. Urology 61:596–600

    PubMed  Google Scholar 

  • Froschermaier SE, Pilarsky CP et al. (1996) Clinical significance of the determination of non-complexed prostate-specific antigen as a marker for prostate carcinoma. Urology 47:525–528

    CAS  PubMed  Google Scholar 

  • Gann PH, Hennekens CH et al. (1995) A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 273:289

    CAS  PubMed  Google Scholar 

  • Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Human Pathol 23:273–279

    CAS  Google Scholar 

  • Granfors T, Modig H et al. (1998) Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvment: a prospective randomized study. J Urol 159:2030–2034

    CAS  PubMed  Google Scholar 

  • Hakenberg OW, Wirth MP et al. (2003) Recommendations for the treatment of localized prostate cancer by permanent interstitial brachytherapy. Urol Int 70:15–20

    CAS  PubMed  Google Scholar 

  • Heinonen OP, Albanes D et al. (1998) Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90:440

    CAS  PubMed  Google Scholar 

  • Holmberg L, Bill-Axelson A et al. (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347:781–789

    PubMed  Google Scholar 

  • Iselin CE, Roberston JE et al. (1999) Radical perineal prostatectomy: oncological outcome during a 20 year period. J Urol 161:163–168

    CAS  PubMed  Google Scholar 

  • Kattan MW, Wheeler TM et al. (1999) Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17:1499–1507

    CAS  PubMed  Google Scholar 

  • Kava BR, Fair WR (1997) Neoadjuvant hormonal therapy for prostate cancer: evolution of a treatment philosophy. Molecular Urol 1:29–37

    CAS  Google Scholar 

  • Kronz JD, Allan CH et al. (2001) Predicting cancer following a diagnosis of high grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol 25:1079–1085

    CAS  PubMed  Google Scholar 

  • Lerner SE, Blute ML et al. (2000) Primary surgery for clinical stage T3 adenocarcinoma of the prostate. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds) Comprehensive textbook of genitourinary oncology, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 789–799

    Google Scholar 

  • McNeal JE (1988) Normal histology of the prostate. Am J Surg Pathol 12:619–633

    CAS  PubMed  Google Scholar 

  • Messing EM, Manola J et al. (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341:1781–1788

    CAS  PubMed  Google Scholar 

  • Narain V, Bianco FJ et al. (2001) How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival? Prostate 49:185–190

    CAS  PubMed  Google Scholar 

  • Partin AW, Mangold LA et al. (2001) Contemporaray update of the prostate cancer staging nomograms (Partin tables) for the new millenium. Urology 51:258–264

    Google Scholar 

  • Partin AW, Yoo JK et al. (1993) The use of prostate-specific antigen, clinical stage and Gleason Score to predict pathological stage in men with localized prostate cancer. J Urol 150:110

    CAS  PubMed  Google Scholar 

  • Puppo P, Perachino M (1997) Clinical stage, prostate-specific antigen and Gleason grade to predict extracapsular disease or nodal metastasis in men with newly diagnosed, previously untreated prostate cancer. A multicenter study. Eur Urol 32:273–279

    CAS  PubMed  Google Scholar 

  • Rogers E, Ohori M et al. (1995) Salavage radical prostatectomy: Outcomes measured by serum prostate specific antigen levels. J Urol 153:104–110

    CAS  PubMed  Google Scholar 

  • Saad F, Schulman CC (2004) Role of bisphopshonates in prostate cancer« Eur Urol 45:26–34

    CAS  PubMed  Google Scholar 

  • Sexton WJ, Lance RE et al. (2001) Adult prostate sarcoma: the M.D.Anderson Cancer Center experience. J Urol 166:521–525

    CAS  PubMed  Google Scholar 

  • Shock NJ, Greulich RC et al. (1994) Normal human aging: the Baltimore Longitudinal Study of Aging. National Institute of Health, Washington/DC, p 2450 (NIH publication no. 84)

    Google Scholar 

  • Steineck G, Helgesen F et al. (2002) Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347:790–796

    PubMed  Google Scholar 

  • Sweat SD, Bergstrahl EJ et al. (2002) Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason Score and patient age. J Urol 168:525–529

    PubMed  Google Scholar 

  • Thompson IM, Goodman PJ et al. (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224

    CAS  PubMed  Google Scholar 

  • Van der Poel HG (2004) Smart drugs in prostate cancer. Eur Urol 45:1–17

    PubMed  Google Scholar 

  • Wawroschek F, Vogt H et al. (2001) Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 166:1715–1719

    CAS  PubMed  Google Scholar 

  • Wirth M (2001) Therapie des lokal begrenzten Prostatakarzinoms. In: Rübben H (Hrsg) Uroonkologie, 3. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Wirth MP, Nippgen J (2003) Chemotherapie beim fortgeschrittenen Prostatakarzinom. Urologe (A) 42:1453–1459

    CAS  Google Scholar 

  • Wirth MP, Tyrell C et al. (2001) Bicalutamide (casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression. Urology 58:146–150

    CAS  PubMed  Google Scholar 

  • Zelefsky M, Leibel S et al. (1998) Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41:491–500

    CAS  PubMed  Google Scholar 

  • Zietman AL, Chung CS et al. (2004) 10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study. J Urol 171:210–214

    CAS  PubMed  Google Scholar 

Literatur

  • Albers P, Weinknecht S, Krege S et al. (2002) Prediction of necrosis after chemotherapy of advanced germ cell tumors — Results of a prospective multicenter trial of the GTCSG. J Urol 167(Suppl): 172 (abstract 690)

    Google Scholar 

  • Albers P, Siener R, Kliesch S et al. (2003) Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group trial. J Clin Oncol 21: 1505–1512

    PubMed  Google Scholar 

  • Classen J, Schmidberger H, Meisner C et al. (2003) Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol 21: 1101–1106

    PubMed  Google Scholar 

  • Collette L, Sylvester RJ, Stenning SP et al. (1999) Impact of the treating institution on survival of patients with »poor-prognosis« metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. J Natl Cancer Inst 91: 839–846

    CAS  PubMed  Google Scholar 

  • De Wit R, Stoter G, Sleijfer DT et al. (1998) Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer. Br J Cancer 78: 828–832

    PubMed  Google Scholar 

  • Dieckmann KP, Loy V (1996) Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 14: 3126–3132

    CAS  PubMed  Google Scholar 

  • Fossa SD, Bokemeyer C, Gerl A et al. (1999 a) Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer 85: 988–997

    CAS  PubMed  Google Scholar 

  • Fossa SD, Horwich A, Russel JM et al. (1999 b) Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. J Clin Oncol 17: 1146–1154

    CAS  PubMed  Google Scholar 

  • Fossa SD, Stenning SP, Gerl A et al. (1999 c) Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer 80: 1392–1399

    CAS  PubMed  Google Scholar 

  • Heidenreich A, Weissbach L, Holtl W et al. German Testicular Cancer Study Group (2001) Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 166: 2161–2165

    CAS  PubMed  Google Scholar 

  • International Germ Cell Cancer Collaborative Group/IGCCCG (1997) The International Germ Cell Consensus Classification: a prognostic factor based staging system for metastatic germ cell cancer. J Clin Oncol 15: 594–603

    Google Scholar 

  • Klepp O, Dahl O, Flodgren P et al. (1997) Risk-adapted treatment of clinical stage I non-seminoma testis cancer. Eur J Cancer 33: 1038–1044

    CAS  PubMed  Google Scholar 

  • Krege S, Schmoll H-J, Souchon R (2001) Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine (EBM). Eur Urol 40: 372–391

    CAS  PubMed  Google Scholar 

  • Miller KD, Loehrer PJ, Gonin R et al. (1997) Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J Clin Oncol 15: 1427–1431

    CAS  PubMed  Google Scholar 

  • Petersen PM, Giwercman A, Daugaard G et al. (2002) Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol 20: 1537–1543

    PubMed  Google Scholar 

  • Read G, Stenning SP, Cullen MH et al. (1992) Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 10: 1762–1768

    CAS  PubMed  Google Scholar 

  • Schmoll HJ, Souchon R, Krege S et al. (2004) European Germ Cell Cancer Consensus Group. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15: 1377–1399

    CAS  PubMed  Google Scholar 

  • Skakkebaek NE, Berthelsen JG, Müller J (1982) Carcinoma in situ of the undescended testis. Urol Clin North Am 9: 377–385

    CAS  PubMed  Google Scholar 

  • Spermon JR, Roeleveld TA, van der Poel HG et al. (2002) Comparison of surveillance and retroperitoneal lymph node dissection in stage I nonseminomatous germ cell tumors. Urology 59: 923–929

    CAS  PubMed  Google Scholar 

  • Steyerberg EW, Keizer HJ, Fossa SD et al. (1995) Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 13: 1177–1187

    CAS  PubMed  Google Scholar 

  • Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, von der Maase H (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance. J Clin Oncol 20: 4448–4452

    PubMed  Google Scholar 

  • Weissbach L, Bussar-Maatz R, Flechtner H et al. (2000) RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? — Results of a prospective multicenter trial including quality of life assessment. Eur Urol 37: 582–594

    CAS  PubMed  Google Scholar 

  • Williams SD, Stablein DM, Einhorn LH et al. (1987) Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 317: 1433–1438

    CAS  PubMed  Google Scholar 

Literatur

  1. Mati W, Lam G, Dahl C, Thorup Andersen J, Balslev E (2002) Leydig cell tumour — a rare testicular tumour. Int Urol Nephrol 33(1): 103–105

    CAS  PubMed  Google Scholar 

  2. Bertram KA, Bratloff B, Hodges GF, Davidson H (1991) Treatment of malignant Leydig cell tumors. Cancer 68: 2324–2329

    CAS  PubMed  Google Scholar 

  3. Giglio M, Medica M, De Rose AF, Germinale F, Ravetti JL, Carmignani G (2003) Testicular sertoli cell tumours and relative sub-types. Analysis of clinical and prognostic features. Urol Int 70(3): 205–210

    PubMed  Google Scholar 

Literatur

  • Ablin AK, Krailo M, Ramsey N et al. (1991) Results of treatment of malignant germ cell tumors in 93 children: a report from the Children’s Cancer Study Group. J Clin Oncol 9: 1782–1789

    CAS  PubMed  Google Scholar 

  • Asmar L, Gehan EA, Newton WA (1994) Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas: report on an international study of four pathology classifications. Cancer 74: 2579–2588

    CAS  PubMed  Google Scholar 

  • Berthold F, Kassenböhmer R, Zieschang J (1994) Multivariate evaluation of prognostic factors in localized neuroblastoma. Am J Pediatr Hematol Oncol 16: 107–115

    CAS  PubMed  Google Scholar 

  • Berthold F, Sahin K, Hero B et al. (1997) The current contribution of molecular factors to risk estimation in neuroblastoma patients. Eur J Cancer 33: 2092–2097

    CAS  PubMed  Google Scholar 

  • Brodeur GM, Pritchard J, Berthold F et al. (1993) Revision of the International Criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 11: 1466–1477

    CAS  PubMed  Google Scholar 

  • Brodeur GM, Maris JM, Yamashiro DJ et al. (1997) Biology and genetics of human neurobastomas. Am J Pediatr Hematol Oncol 19: 93–101

    CAS  Google Scholar 

  • Clericuzio CL, Johnson C (1995) Screening for Wilm’s tumor in high-risk individuals. Hematol Oncol Clin North Am 9: 1253–1265

    CAS  PubMed  Google Scholar 

  • Crist W, Gehan EA, Abdelsalam HR et al. (1995) The third intergroup rhabdomyosarcoma study. J Clin Oncol 13: 610–615

    CAS  PubMed  Google Scholar 

  • De Vries JD (1995) Paratesticular rhabdomyosarcoma. World J Urol 13: 213–218

    Google Scholar 

  • Göbel U (2001) Weichteilsarkome. In: Rübben H (Hrsg) Uro-Onkologie. Springer, Berlin Heidelberg New York Tokyo, S 553–567

    Google Scholar 

  • Godzinsiki J, Tournade MF, de Kraker J et al. (1998) Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology Trial and Study »SIOP 9«. International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee. Eur J Pediatr Surg 8: 83–86

    Google Scholar 

  • Graf N, Reinhard H. (2003) Wilms-Tumoren. Diagnostik und Therapie. Urologe A 42: 391–409

    Google Scholar 

  • Graf N, Tournade MF, de Kraker J (2000) The role of preoperative chemotherapy in the management of Wilm’s tumor. Urol Clin North Am 27: 443–454

    CAS  PubMed  Google Scholar 

  • Green DM, Coppes MJ (1995) Future directions in clinical research in Wilm’s tumour. Hematol Oncol Clin North Am 9: 1329–1339

    CAS  PubMed  Google Scholar 

  • Hale GA, Marina NM, Jones-Wallace D et al. (1999) Late effects of treatment for germ cell tumors in childhood and adolescence. J Pediatr Hematol Oncol 21: 115–122

    CAS  PubMed  Google Scholar 

  • Havers W, Goepel M, Rübben H (2001) Nephroblastom. In: Rübben H (Hrsg) Uro-Onkologie. Springer, Berlin Heidelberg New York Tokyo, S 568–587

    Google Scholar 

  • Hays DM, Raney RB, Wharam MD et al. (1995) Children with vesical rhabdomyosarcoma treated by partial cystectomy with neoadjuvant chemotherapy with and without radiotherapy: a report from the Intergroup Rhabdomyosarcoma Study Committee. J Pediatr Hematol Oncol 17: 46–52

    CAS  PubMed  Google Scholar 

  • Huff V (1998) Wilms-tumor genetics. Am J Med Genet 79: 260–267

    CAS  PubMed  Google Scholar 

  • Jereb B, Tournade MF, Lemerle J et al. (1980) Lymph node invasion and prognosis in nephroblastoma. Cancer 45:1632–1636

    CAS  PubMed  Google Scholar 

  • Kardos G, d’Orleire F, Koscielniak E, Keim M, Treuner J (1990) Do alveolar and embryonal rhabdomyosarcomas have a different prognosis? Med Pediatr Oncol 18: 415–418

    Google Scholar 

  • Koscielniak E, Jürgens H, Winkler K (1992) Treatment of soft tissue sarcoma in childhood and adolescence. Cancer 70: 2557–2567

    CAS  PubMed  Google Scholar 

  • Kremers B, Havers W (2001) Neuroblastom. In: Rübben H (Hrsg) Uro-Onkologie. Springer, Berlin Heidelberg New York Tokyo, S 540–552

    Google Scholar 

  • Kuo JY, Hsieh YL, Chin T et al. (1999) Postchemotherapy retroperitoneal residual mass in infantile yolk sac tumor. Int J Urol 6: 116–118

    CAS  PubMed  Google Scholar 

  • Lawrence W, Beltangandy M, Christ W (1987) Lymphatic metastases with childhood rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study. Cancer 60: 910–915

    PubMed  Google Scholar 

  • National Wilm’s Tumor Study Committee (1990) Wilm’s tumor: a status report. J Clin Oncol 9: 877–897

    Google Scholar 

  • Ortega JA, Rowland J, Monforte H et al. (2000) Presence of well-differentiated rhabdomyoblasts at the end of therapy for pelvic rhabdomyosarcoma: implications for the outcome. J Pediatr Hematol Oncol 22: 106–111

    CAS  PubMed  Google Scholar 

  • Pearse I, Glick RD, Abrahamson SJ et al. (1999) Testicular-sparing surgery for benign testicular tumors. J Pediatr Surg 34: 1000–1003

    CAS  PubMed  Google Scholar 

  • Peuchmaur M, d’Amore ESG, Joshi VV et al. (2003) Revision of the International Neuroblastoma Pathology Classification. Cancer 98: 2274–2281

    PubMed  Google Scholar 

  • Pinkerton CR, Braodbent V, Horwich A et al. (1990) A carboplatin based regimen for malignant germ cell tumors in children. Br J Cancer 62: 257–261

    CAS  PubMed  Google Scholar 

  • Rushton G, Belman AB, Sesterhenn I et al. (1990) Testicular sparing surgery for prepubertal teratoma of the testis: a clinical and pathological study. J Urol 144: 726–730

    CAS  PubMed  Google Scholar 

  • Shimada H, Ambros IM, Dehner LP et al. (1999) The International Neuroblastoma Pathology Classification (the Shimada System). Cancer 86: 364–372

    CAS  PubMed  Google Scholar 

  • Wiener ES, Anderson JR, Ojimba JI et al. (2001) Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymphadenectomy necessary for adolescents with resected paratesticular rhabdomyosarcoma. Semin Pediatr Surg 10: 146–152

    CAS  PubMed  Google Scholar 

  • Woods WG, Tuchmann M, Bernstein M et al. (1998) Screening infants for neuroblastoma does not reduce the incidence of poor-prognosis disease. Med Pediatr Oncol 31: 450–454

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Urologie und Kinderurologie, Justus-Liebig-Universität Gießen, Rudolf-Buchheim-Str. 7, 35392, Gießen

    Dr. med. V. Rohde

  2. Fachabteilung Innere Medizin, Schwerpunkt Gastroenterologie und Hepatologie, Evangelisches Krankenhaus Herne, Wiescherstr. 24, 44623, Herne

    Dr. med. M. Cziborra

  3. Schwerpunkt Gastroenterologie und Hepatologie, Evangelisches Krankenhaus Herne, Wiescherstr. 24, 44623, Herne

    Prof. Dr. med. F. Jockenhövel (Chefarzt der Fachabteilung Innere Medizin)

  4. Klinik für Urologie und Kinderurologie, Universitätsklinikum Ulm, Prittwitzstr. 43, 89070, Ulm

    Dr. med. J. Simon & Prof. Dr. med. J. E. Gschwend

  5. Klinik und Poliklinik für Urologie, Medizinische Einrichtungen der Universität zu Köln, Joseph-Stelzmann-Str. 9, 50931, Köln

    Prof. Dr. med. A. Heidenreich, Dr. med. C. H. Ohlmann & E. Özgür

  6. Klinik und Poliklinik für Urologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden

    Priv.-Doz. Dr. med. O. W. Hakenberg & Prof. Dr. med. M. P. Wirth

  7. Urologische Abteilung, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081, Ulm

    Dr. med. H. U. Schmelz

  8. Klinikum Kassel, Mönchebergstr. 41-43, 34125, Kassel

    Prof. Dr. med. P. Albers (Direktor der Klinik für Urologie)

Authors
  1. Dr. med. V. Rohde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. M. Cziborra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. med. F. Jockenhövel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dr. med. J. Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prof. Dr. med. J. E. Gschwend
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Prof. Dr. med. A. Heidenreich
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dr. med. C. H. Ohlmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Priv.-Doz. Dr. med. O. W. Hakenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Prof. Dr. med. M. P. Wirth
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Dr. med. H. U. Schmelz
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Prof. Dr. med. P. Albers
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. E. Özgür
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Rohde, V. et al. (2006). Onkologie und Tumoren. In: Facharztwissen Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-32986-2_3

Download citation

  • DOI: https://doi.org/10.1007/3-540-32986-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20009-3

  • Online ISBN: 978-3-540-32986-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation